Steven Lehrer brings over 30 years of experience starting, growing and running life science-based businesses focused on commercializing new technology and expanding businesses globally. Steve has extensive experience in pharmaceutical, biopharmaceutical and biosimilar R&D, regulatory, operations and commercialization. In addition, he had led the development and commercialization of several molecular genetic diagnostic tests and developed outcomes databases for bioinformatics and healthcare econometric modeling. Steve has built and run businesses in the US, EU, Brazil, India, Japan and SEA.
Steve currently sits on the Board of Directors of 2 life science companies and provides strategy and implementation advise to several CEO/senior management teams on a wide range of topics from commercial efforts through operations /business development, product development, portfolio planning and setting up international operations. Previously he was Head of Biologicals at Cipla Ltd., CEO at Cipla BioTec, President at Glycominds, EVP at Adamas Pharma, CEO at GeneOs Ltd, CEO at DNA Sciences (2000-2003) and division President at Monsanto). Prior to Monsanto, Steve worked for McKinsey & Co. and P&G.
Steve has a Master's Degree from The Graduate School of Business at Harvard University and a BSE in Chemical Engineering and a BA in Economics from the University of Maryland, College Park.